data_2kji_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kji _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 11' ' ' ILE . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 31' ' ' ALA . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.584 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' A' ' 10' ' ' LEU . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' CB ' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 15.5 t30 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.42 ' HB2' ' CG ' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 11' ' ' ILE . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CG ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.568 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.631 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' HG11 ' A' ' 17' ' ' VAL . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' CG ' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.61 ' HB ' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.565 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' CB ' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.549 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.54 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.596 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 HD12 ' CG ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' CG ' HD12 ' A' ' 21' ' ' LEU . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.473 ' OH ' ' O ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.596 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.573 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' O ' HG21 ' A' ' 11' ' ' ILE . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 ' CG1' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.556 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 32' ' ' THR . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 8' ' ' ARG . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 31' ' ' ALA . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.572 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG2' ' SG ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 ' O ' ' CG ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 3.2 t-20 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.566 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.531 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.213 -0.837 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' O ' ' CD2' ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.538 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.601 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.531 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.514 ' N ' HG21 ' A' ' 17' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 11.9 mm-40 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.477 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.601 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.546 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' HG3' HD21 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.58 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.544 ' CG2' ' SG ' ' A' ' 18' ' ' CYS . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.545 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' ' CE2' ' A' ' 43' ' ' TYR . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.569 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.532 ' CB ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.729 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 43' ' ' TYR . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 14' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.5 t30 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.557 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' N ' HG23 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.587 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.478 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' A' ' 13' ' ' LEU . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.573 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.475 ' N ' HG21 ' A' ' 17' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' CB ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 13' ' ' LEU . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.538 HD12 ' CZ ' ' A' ' 43' ' ' TYR . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.543 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' OD2' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.52 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' CB ' HD12 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.538 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.537 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HD3' HG21 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.546 ' O ' ' CG2' ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD1' ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 14' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.534 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.52 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.59 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.573 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.61 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.473 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.61 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 13' ' ' LEU . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.521 ' N ' HD21 ' A' ' 10' ' ' LEU . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.539 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.609 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.721 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.536 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' ILE . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD22 ' CB ' ' A' ' 31' ' ' ALA . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 17' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 32' ' ' THR . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 45' ' ' ARG . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.534 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.604 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 14' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.604 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.592 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.628 ' CB ' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.628 ' HB2' ' CB ' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.514 HD11 ' OH ' ' A' ' 43' ' ' TYR . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CG1' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.428 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.533 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.534 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.551 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.603 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.456 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.558 ' CD2' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.607 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.43 148.51 51.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.299 -1.119 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 t -95.14 -164.54 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.623 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' HD3' ' N ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -67.8 155.59 38.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.2 97.1 2.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 11' ' ' ILE . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 31' ' ' ALA . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' A' ' 10' ' ' LEU . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' CB ' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 15.5 t30 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.778 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 148.69 31.03 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.419 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 8.1 t -77.03 -166.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -103.96 158.94 16.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.509 -0.744 . . . . 0.0 109.159 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.42 ' HB2' ' CG ' ' A' ' 9' ' ' LYS . . . -165.18 102.34 0.75 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.568 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' HG23 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 11' ' ' ILE . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CG ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.568 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.631 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' HG11 ' A' ' 17' ' ' VAL . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.494 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' CG ' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.61 ' HB ' ' CE2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' CE ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.565 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' CB ' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.549 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.862 0 N-CA-C 119.364 2.506 . . . . 0.0 119.364 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.65 153.48 22.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.186 -1.185 . . . . 0.0 109.453 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.2 t -149.04 -163.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 1.4 ttm180 -61.73 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.581 0.705 . . . . 0.0 109.634 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' ARG . . . 165.01 112.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.54 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.596 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD12 ' CG ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' CG ' HD12 ' A' ' 21' ' ' LEU . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' OH ' ' O ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.596 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.573 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.494 2.558 . . . . 0.0 119.494 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -56.34 135.63 53.75 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.111 -1.229 . . . . 0.0 109.645 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' ARG . 14.2 t -64.14 -164.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 34.44 -153.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.519 0.676 . . . . 0.0 109.896 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' N ' ' HD3' ' A' ' 4' ' ' ARG . . . 179.45 103.44 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' O ' HG21 ' A' ' 11' ' ' ILE . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 ' CG1' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.821 0 N-CA-C 119.345 2.498 . . . . 0.0 119.345 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.72 117.22 2.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.169 -1.195 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 4.9 t -135.27 -166.85 1.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' N ' ' OG1' ' A' ' 3' ' ' THR . 2.1 tpp180 -114.86 149.96 36.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 109.533 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . -109.19 82.54 1.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.556 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 32' ' ' THR . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.912 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.18 146.44 38.98 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -1.117 . . . . 0.0 109.644 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -104.48 -164.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -57.13 150.55 17.18 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.136 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.52 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -132.1 87.96 2.5 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 4' ' ' ARG . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 8' ' ' ARG . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 31' ' ' ALA . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.572 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG2' ' SG ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.477 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 ' O ' ' CG ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 3.2 t-20 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.566 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.592 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.792 0 N-CA-C 119.441 2.536 . . . . 0.0 119.441 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.61 156.85 15.65 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.155 -1.203 . . . . 0.0 109.488 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 t -142.13 -161.76 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.684 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.413 ' CG ' ' H ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -124.31 -162.03 1.04 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.738 0.78 . . . . 0.0 109.647 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . 169.82 117.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' O ' ' CD2' ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.601 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.531 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.514 ' N ' HG21 ' A' ' 17' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 11.9 mm-40 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.477 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.601 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.841 0 N-CA-C 119.359 2.504 . . . . 0.0 119.359 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.65 154.46 6.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.281 -1.129 . . . . 0.0 109.578 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 2.2 t -125.54 -168.3 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.785 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -108.51 143.47 37.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.447 -0.783 . . . . 0.0 109.862 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' N ' ' HD2' ' A' ' 4' ' ' ARG . . . -107.02 82.67 1.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.546 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' HG3' HD21 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.58 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.544 ' CG2' ' SG ' ' A' ' 18' ' ' CYS . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.545 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' ' CE2' ' A' ' 43' ' ' TYR . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.569 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.15 136.98 42.89 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.305 -1.115 . . . . 0.0 109.677 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 t -157.9 -165.04 1.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -98.69 -148.22 0.33 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.698 0.761 . . . . 0.0 109.349 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.532 ' CB ' ' HG3' ' A' ' 9' ' ' LYS . . . 163.64 115.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 43' ' ' TYR . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 14' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.5 t30 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HG2' ' OD1' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.557 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' N ' HG23 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.587 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.812 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -68.16 162.46 24.78 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 t -125.68 -161.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.5 tmt_? -52.95 148.67 7.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.507 0.67 . . . . 0.0 109.343 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -157.7 98.28 1.64 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.478 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' A' ' 13' ' ' LEU . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.573 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.475 ' N ' HG21 ' A' ' 17' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' CB ' HD13 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.846 0 N-CA-C 119.425 2.53 . . . . 0.0 119.425 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.56 139.64 39.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -1.132 . . . . 0.0 109.193 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 3.9 t -63.45 -168.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' N ' ' OG1' ' A' ' 3' ' ' THR . 6.0 tpp180 -115.65 149.73 37.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -0.762 . . . . 0.0 109.319 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -120.44 80.85 1.67 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 13' ' ' LEU . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.538 HD12 ' CZ ' ' A' ' 43' ' ' TYR . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.543 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' OD2' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.52 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' CB ' HD12 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.538 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.537 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.876 0 N-CA-C 119.45 2.54 . . . . 0.0 119.45 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 5.8 pt-20 -63.76 127.68 32.44 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.29 -1.124 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.4 t -152.5 -165.65 2.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.5 tpp180 -91.68 156.02 17.89 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.567 -0.708 . . . . 0.0 109.334 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -144.93 97.61 3.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HD3' HG21 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' O ' ' CG2' ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 ' CG1' HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.87 0 N-CA-C 119.387 2.515 . . . . 0.0 119.387 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -63.92 -177.63 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.218 -1.166 . . . . 0.0 109.699 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.497 ' O ' ' C ' ' A' ' 4' ' ' ARG . 6.9 t -126.82 -165.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER 33.2 -140.17 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.489 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' N ' ' CD ' ' A' ' 4' ' ' ARG . . . 166.36 110.85 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' O ' HD21 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' CD1' ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 14' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.534 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.52 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' SG ' ' CE2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.59 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.902 0 N-CA-C 119.491 2.556 . . . . 0.0 119.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 140.26 24.15 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.115 -1.226 . . . . 0.0 109.431 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 10.1 t -136.1 -164.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 109.65 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HG2' ' NH1' ' A' ' 4' ' ' ARG . 2.3 tpp85 -84.87 154.42 22.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -131.34 91.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 31' ' ' ALA . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.573 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 18' ' ' CYS . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.473 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' HD23 ' A' ' 10' ' ' LEU . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' NH2' ' A' ' 4' ' ' ARG . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.61 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.839 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.77 162.89 1.57 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -1.118 . . . . 0.0 109.731 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.9 t -152.39 -164.7 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.7 tpp180 -93.27 156.47 16.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.602 0.715 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -118.45 98.01 6.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 13' ' ' LEU . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' N ' HD21 ' A' ' 10' ' ' LEU . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.539 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.609 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.584 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.554 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.789 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -176.62 0.05 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 4' ' ' ARG . 15.4 t -154.18 -164.8 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 33.08 -152.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.624 0.726 . . . . 0.0 110.306 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.564 ' N ' ' HD3' ' A' ' 4' ' ' ARG . . . 160.27 112.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.536 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' ILE . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD22 ' CB ' ' A' ' 31' ' ' ALA . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 17' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' CB ' HD22 ' A' ' 10' ' ' LEU . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 32' ' ' THR . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.598 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 45' ' ' ARG . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.534 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.836 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -64.71 145.27 56.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.345 -1.091 . . . . 0.0 109.638 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' GLU . 7.3 t -56.82 -160.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.588 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.552 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -43.65 148.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.552 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -139.51 92.84 2.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.604 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 14' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.604 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' CB ' HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.592 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HA ' HD12 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.906 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.2 pm0 -107.55 143.71 35.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.077 -1.249 . . . . 0.0 109.466 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.2 t -145.04 -162.85 1.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.648 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.576 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 9.2 ttm180 -51.87 148.37 5.9 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.608 0.718 . . . . 0.0 109.344 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.628 ' CB ' ' HB2' ' A' ' 9' ' ' LYS . . . -139.53 90.37 2.4 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.628 ' HB2' ' CB ' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.514 HD11 ' OH ' ' A' ' 43' ' ' TYR . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.518 HD23 ' CG1' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.592 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.428 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.54 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.533 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 131.83 46.87 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.157 -1.202 . . . . 0.0 109.42 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -160.61 -163.82 1.13 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.685 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -64.11 147.54 52.0 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.565 -0.709 . . . . 0.0 109.442 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 9' ' ' LYS . . . -107.52 75.33 1.01 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 31' ' ' ALA . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 11' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.534 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.551 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 156.68 17.03 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -1.13 . . . . 0.0 109.867 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -158.05 -164.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.605 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.2 tmm_? -64.83 153.82 38.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -144.18 95.67 2.76 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 6' ' ' CYS . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.603 ' CG1' ' CG1' ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.456 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.558 ' CD2' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HD3' ' CD2' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' A' ' 43' ' ' TYR . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.568 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' CG1' ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.607 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.749 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.734 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.832 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.726 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG3' HD13 ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 13.1 t-20 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.985 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.759 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' SER . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.654 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.882 HD11 HD11 ' A' ' 44' ' ' ILE . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 44' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.875 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB3' ' NZ ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.639 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.611 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.999 HG12 HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.715 ' O ' HD23 ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.917 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.763 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.994 HG12 ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.043 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.777 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.521 ' HE1' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.994 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.043 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.603 ' O ' HD23 ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.737 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.833 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.941 HG12 HG12 ' A' ' 44' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.931 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.811 ' O ' HG22 ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.643 ' CB ' HD11 ' A' ' 10' ' ' LEU . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.591 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.706 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.67 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.751 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.0 HG12 HG12 ' A' ' 44' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.863 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.912 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.734 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.0 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.544 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.817 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.662 ' O ' HD23 ' A' ' 10' ' ' LEU . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.817 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.577 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.903 HG12 HG12 ' A' ' 44' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.796 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 31.6 t30 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.903 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.213 -0.837 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.697 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.816 ' O ' HD22 ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.976 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.011 HG12 HG12 ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 14.3 mm100 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.924 ' O ' HG22 ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.764 HG21 ' O ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.775 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.011 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.764 ' O ' HG21 ' A' ' 30' ' ' ILE . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 13' ' ' LEU . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.674 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.063 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.729 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.815 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.765 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.643 ' ND2' ' HG2' ' A' ' 25' ' ' GLN . 1.1 t-20 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.643 ' HG2' ' ND2' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.898 ' O ' HG22 ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.815 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.686 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.97 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.042 HG12 HG12 ' A' ' 44' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.97 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.961 ' O ' HG22 ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.768 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.042 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.914 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.57 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.57 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.932 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.845 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.939 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.614 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.845 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.864 ' O ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.932 ' CB ' HD11 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.627 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HD3' HG23 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.794 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.939 HG12 HG12 ' A' ' 44' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.861 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' CD ' ' HG2' ' A' ' 50' ' ' PRO . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.832 ' O ' HG22 ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.974 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.794 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.939 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.974 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.604 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.942 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.925 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.018 HG12 HG12 ' A' ' 44' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.925 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.942 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.018 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.028 HG12 HG12 ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' CB ' HD11 ' A' ' 10' ' ' LEU . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.028 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.673 ' O ' HD23 ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.748 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.058 HG12 HG12 ' A' ' 44' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.916 ' HB3' HD13 ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.822 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.553 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.058 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.721 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' HD23 ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HD2' ' OG ' ' A' ' 12' ' ' SER . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.495 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.966 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.966 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.691 ' CB ' HD11 ' A' ' 10' ' ' LEU . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD2' HG22 ' A' ' 44' ' ' ILE . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.593 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.566 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.743 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.913 HG12 HG12 ' A' ' 44' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.8 ' O ' HG22 ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.808 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.652 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mt-30 -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' OH ' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.913 HG12 HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 11' ' ' ILE . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.773 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.829 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.3 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.755 ' O ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.777 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.532 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.783 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.797 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.927 HD13 ' HG3' ' A' ' 24' ' ' PRO . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.852 HD11 HD11 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.979 HD13 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.783 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.65 ' HB2' HD21 ' A' ' 10' ' ' LEU . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.519 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.905 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.009 HG12 HG12 ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' C ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD21 ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 1.022 ' O ' HG22 ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.648 ' CB ' HD11 ' A' ' 10' ' ' LEU . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.009 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.568 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.43 148.51 51.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.299 -1.119 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 t -95.14 -164.54 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.623 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HD3' ' N ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -67.8 155.59 38.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.2 97.1 2.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.749 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.734 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.832 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.726 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG3' HD13 ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 13.1 t-20 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.985 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.759 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.778 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 148.69 31.03 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 8.1 t -77.03 -166.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -103.96 158.94 16.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.509 -0.744 . . . . 0.0 109.159 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -165.18 102.34 0.75 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' SER . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.882 HD11 HD11 ' A' ' 44' ' ' ILE . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 44' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.875 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB3' ' NZ ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.639 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.611 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.999 HG12 HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.862 0 N-CA-C 119.364 2.506 . . . . 0.0 119.364 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.65 153.48 22.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.186 -1.185 . . . . 0.0 109.453 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.2 t -149.04 -163.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 1.4 ttm180 -61.73 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.581 0.705 . . . . 0.0 109.634 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 165.01 112.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.715 ' O ' HD23 ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.917 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.763 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.994 HG12 ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.043 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.777 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.521 ' HE1' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.994 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.043 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.494 2.558 . . . . 0.0 119.494 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -56.34 135.63 53.75 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.111 -1.229 . . . . 0.0 109.645 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' ARG . 14.2 t -64.14 -164.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.575 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 34.44 -153.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.519 0.676 . . . . 0.0 109.896 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.575 ' N ' ' HD3' ' A' ' 4' ' ' ARG . . . 179.45 103.44 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.603 ' O ' HD23 ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.737 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.833 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.941 HG12 HG12 ' A' ' 44' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.931 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.811 ' O ' HG22 ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.643 ' CB ' HD11 ' A' ' 10' ' ' LEU . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.591 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.706 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.821 0 N-CA-C 119.345 2.498 . . . . 0.0 119.345 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.72 117.22 2.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.169 -1.195 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 4.9 t -135.27 -166.85 1.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' N ' ' OG1' ' A' ' 3' ' ' THR . 2.1 tpp180 -114.86 149.96 36.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 109.533 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . -109.19 82.54 1.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.751 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.0 HG12 HG12 ' A' ' 44' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.863 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.912 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.734 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.0 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.544 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.912 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.18 146.44 38.98 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -1.117 . . . . 0.0 109.644 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -104.48 -164.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -57.13 150.55 17.18 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.136 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.817 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . -132.1 87.96 2.5 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.662 ' O ' HD23 ' A' ' 10' ' ' LEU . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.817 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.577 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.903 HG12 HG12 ' A' ' 44' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.796 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 31.6 t30 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.903 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.792 0 N-CA-C 119.441 2.536 . . . . 0.0 119.441 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.61 156.85 15.65 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.155 -1.203 . . . . 0.0 109.488 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 4' ' ' ARG . 11.4 t -142.13 -161.76 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.684 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -124.31 -162.03 1.04 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.738 0.78 . . . . 0.0 109.647 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 169.82 117.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.697 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.816 ' O ' HD22 ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.976 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.011 HG12 HG12 ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 14.3 mm100 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.924 ' O ' HG22 ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.764 HG21 ' O ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.775 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.011 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.764 ' O ' HG21 ' A' ' 30' ' ' ILE . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.841 0 N-CA-C 119.359 2.504 . . . . 0.0 119.359 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.65 154.46 6.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.281 -1.129 . . . . 0.0 109.578 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 2.2 t -125.54 -168.3 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.785 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -108.51 143.47 37.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.447 -0.783 . . . . 0.0 109.862 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 4' ' ' ARG . . . -107.02 82.67 1.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 13' ' ' LEU . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.674 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.063 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.15 136.98 42.89 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.305 -1.115 . . . . 0.0 109.677 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 t -157.9 -165.04 1.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -98.69 -148.22 0.33 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.698 0.761 . . . . 0.0 109.349 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 163.64 115.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.815 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.765 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.643 ' ND2' ' HG2' ' A' ' 25' ' ' GLN . 1.1 t-20 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.643 ' HG2' ' ND2' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.898 ' O ' HG22 ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.686 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.812 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -68.16 162.46 24.78 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 t -125.68 -161.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.5 tmt_? -52.95 148.67 7.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.507 0.67 . . . . 0.0 109.343 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -157.7 98.28 1.64 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.97 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.042 HG12 HG12 ' A' ' 44' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.97 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.961 ' O ' HG22 ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.768 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.042 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.914 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.846 0 N-CA-C 119.425 2.53 . . . . 0.0 119.425 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.56 139.64 39.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -1.132 . . . . 0.0 109.193 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 3.9 t -63.45 -168.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' N ' ' OG1' ' A' ' 3' ' ' THR . 6.0 tpp180 -115.65 149.73 37.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -0.762 . . . . 0.0 109.319 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.57 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . -120.44 80.85 1.67 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.57 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.932 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.845 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.939 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.614 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.845 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.864 ' O ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.932 ' CB ' HD11 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.627 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.876 0 N-CA-C 119.45 2.54 . . . . 0.0 119.45 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 5.8 pt-20 -63.76 127.68 32.44 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.29 -1.124 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.4 t -152.5 -165.65 2.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.5 tpp180 -91.68 156.02 17.89 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.567 -0.708 . . . . 0.0 109.334 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -144.93 97.61 3.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HD3' HG23 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.794 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.939 HG12 HG12 ' A' ' 44' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.861 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' CD ' ' HG2' ' A' ' 50' ' ' PRO . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.832 ' O ' HG22 ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.974 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.794 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.939 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.974 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.87 0 N-CA-C 119.387 2.515 . . . . 0.0 119.387 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -63.92 -177.63 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.218 -1.166 . . . . 0.0 109.699 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.497 ' O ' ' C ' ' A' ' 4' ' ' ARG . 6.9 t -126.82 -165.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 33.2 -140.17 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.489 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 166.36 110.85 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.604 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.942 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.925 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.018 HG12 HG12 ' A' ' 44' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.595 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.925 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.942 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.018 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.902 0 N-CA-C 119.491 2.556 . . . . 0.0 119.491 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 140.26 24.15 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.115 -1.226 . . . . 0.0 109.431 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 10.1 t -136.1 -164.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 109.65 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' NH2' ' SG ' ' A' ' 35' ' ' CYS . 2.3 tpp85 -84.87 154.42 22.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -131.34 91.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.028 HG12 HG12 ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' CB ' HD11 ' A' ' 10' ' ' LEU . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' NH2' ' A' ' 4' ' ' ARG . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.028 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.839 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.77 162.89 1.57 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -1.118 . . . . 0.0 109.731 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.9 t -152.39 -164.7 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.7 tpp180 -93.27 156.47 16.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.602 0.715 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -118.45 98.01 6.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.673 ' O ' HD23 ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.748 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.058 HG12 HG12 ' A' ' 44' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.916 ' HB3' HD13 ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.822 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.058 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.789 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -176.62 0.05 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 4' ' ' ARG . 15.4 t -154.18 -164.8 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.689 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 33.08 -152.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.624 0.726 . . . . 0.0 110.306 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 160.27 112.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' HD23 ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HD2' ' OG ' ' A' ' 12' ' ' SER . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.966 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.966 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.691 ' CB ' HD11 ' A' ' 10' ' ' LEU . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD2' HG22 ' A' ' 44' ' ' ILE . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.836 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -64.71 145.27 56.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.345 -1.091 . . . . 0.0 109.638 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 4' ' ' ARG . 7.3 t -56.82 -160.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.588 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -43.65 148.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.55 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -139.51 92.84 2.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.593 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.566 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.743 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.913 HG12 HG12 ' A' ' 44' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.8 ' O ' HG22 ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.808 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.652 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mt-30 -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' OH ' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.913 HG12 HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.906 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 2.2 pm0 -107.55 143.71 35.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.077 -1.249 . . . . 0.0 109.466 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.2 t -145.04 -162.85 1.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.648 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.579 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 9.2 ttm180 -51.87 148.37 5.9 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.608 0.718 . . . . 0.0 109.344 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . -139.53 90.37 2.4 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 11' ' ' ILE . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.773 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.829 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.3 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.755 ' O ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.777 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.532 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 131.83 46.87 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.157 -1.202 . . . . 0.0 109.42 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -160.61 -163.82 1.13 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.685 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -64.11 147.54 52.0 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.565 -0.709 . . . . 0.0 109.442 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . -107.52 75.33 1.01 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.783 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.797 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.927 HD13 ' HG3' ' A' ' 24' ' ' PRO . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.852 HD11 HD11 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.979 HD13 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.783 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.65 ' HB2' HD21 ' A' ' 10' ' ' LEU . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.519 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 156.68 17.03 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -1.13 . . . . 0.0 109.867 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -158.05 -164.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.605 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.2 tmm_? -64.83 153.82 38.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -144.18 95.67 2.76 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.905 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.009 HG12 HG12 ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' C ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD21 ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 1.022 ' O ' HG22 ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' CB ' HD11 ' A' ' 10' ' ' LEU . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.009 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.568 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.749 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.734 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.832 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.726 HD13 ' C ' ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG3' HD13 ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 15.5 t30 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.985 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.759 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' SER . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.654 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.882 HD11 HD11 ' A' ' 44' ' ' ILE . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 44' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.875 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB3' ' NZ ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.639 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.611 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.999 HG12 HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.715 ' O ' HD23 ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.917 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.763 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.994 HG12 ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.043 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.777 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.521 ' HE1' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.994 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.043 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.603 ' O ' HD23 ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.737 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.833 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.941 HG12 HG12 ' A' ' 44' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.931 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.811 ' O ' HG22 ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.643 ' CB ' HD11 ' A' ' 10' ' ' LEU . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.591 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.706 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.67 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.751 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.0 HG12 HG12 ' A' ' 44' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.863 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.912 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.734 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.0 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.544 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.817 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.662 ' O ' HD23 ' A' ' 10' ' ' LEU . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.817 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.577 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.758 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.903 HG12 HG12 ' A' ' 44' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.796 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 3.2 t-20 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.903 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.213 -0.837 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.697 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.816 ' O ' HD22 ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.976 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.011 HG12 HG12 ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 11.9 mm-40 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.924 ' O ' HG22 ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.764 HG21 ' O ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.775 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.011 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.764 ' O ' HG21 ' A' ' 30' ' ' ILE . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 13' ' ' LEU . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.674 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.063 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 C--O 1.215 -0.729 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.815 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.765 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.5 t30 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.898 ' O ' HG22 ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.815 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.686 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.97 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.042 HG12 HG12 ' A' ' 44' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.97 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.961 ' O ' HG22 ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.768 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.042 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.914 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.57 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.57 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.932 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.845 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.939 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' OD2' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.614 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.845 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.864 ' O ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.932 ' CB ' HD11 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.627 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HD3' HG23 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.794 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.939 HG12 HG12 ' A' ' 44' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.861 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' CD ' ' HG2' ' A' ' 50' ' ' PRO . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.832 ' O ' HG22 ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.974 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.794 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.939 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.974 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.604 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.942 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.925 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.018 HG12 HG12 ' A' ' 44' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.925 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.942 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.018 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.028 HG12 HG12 ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' CB ' HD11 ' A' ' 10' ' ' LEU . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.028 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.673 ' O ' HD23 ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.748 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.058 HG12 HG12 ' A' ' 44' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.916 ' HB3' HD13 ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.822 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.553 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.058 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.721 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' HD23 ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HD2' ' OG ' ' A' ' 12' ' ' SER . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.495 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.966 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.966 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.691 ' CB ' HD11 ' A' ' 10' ' ' LEU . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD2' HG22 ' A' ' 44' ' ' ILE . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.593 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.566 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.743 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.913 HG12 HG12 ' A' ' 44' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.8 ' O ' HG22 ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.808 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.652 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' OH ' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.913 HG12 HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 11' ' ' ILE . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.773 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.829 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.755 ' O ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.777 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.532 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.783 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.797 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.927 HD13 ' HG3' ' A' ' 24' ' ' PRO . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.852 HD11 HD11 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.979 HD13 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.783 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.65 ' HB2' HD21 ' A' ' 10' ' ' LEU . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.519 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.905 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.009 HG12 HG12 ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' C ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD21 ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 1.022 ' O ' HG22 ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.648 ' CB ' HD11 ' A' ' 10' ' ' LEU . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.009 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.568 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.442 2.537 . . . . 0.0 119.442 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.43 148.51 51.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.299 -1.119 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 t -95.14 -164.54 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.623 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HD3' ' N ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -67.8 155.59 38.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.2 97.1 2.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 33.3 m -135.84 -65.23 0.6 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -58.93 -38.02 92.03 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -71.34 -38.01 71.67 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -63.71 -32.28 73.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.692 -0.63 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.749 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.1 mm? -65.49 -43.26 90.75 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.11 -0.994 . . . . 0.0 109.204 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.734 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -81.85 -22.05 10.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.072 -1.018 . . . . 0.0 108.555 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 15' ' ' MET . 12.9 t -73.47 -55.96 5.67 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.456 -0.778 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.832 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.21 -34.7 76.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.998 -1.064 . . . . 0.0 109.549 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 44' ' ' ILE . 34.9 m -78.13 -31.22 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.469 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -52.07 -23.05 4.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.588 -1.32 . . . . 0.0 107.894 178.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.48 -22.67 18.11 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -91.46 -37.5 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.325 -0.859 . . . . 0.0 109.137 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.2 m -99.17 -28.45 13.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.091 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 61.47 46.9 93.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 54.06 32.29 15.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -1.092 . . . . 0.0 109.201 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD13 ' C ' ' A' ' 21' ' ' LEU . 3.0 tm? -100.95 -52.71 3.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 0.0 109.275 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.1 m -74.41 -108.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 108.744 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 21.5 p30 173.89 122.99 0.1 Allowed Pre-proline 0 C--N 1.313 -0.989 0 O-C-N 120.531 -1.355 . . . . 0.0 110.411 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.734 ' HG3' HD13 ' A' ' 11' ' ' ILE . 32.4 Cg_endo -82.69 48.93 2.92 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.217 1.945 . . . . 0.0 108.795 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG3' ' OD1' ' A' ' 23' ' ' ASN . 31.1 mt-30 -59.31 134.36 56.93 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.436 0.636 . . . . 0.0 110.383 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 25' ' ' GLN . 1.7 tt0 42.3 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.505 -0.747 . . . . 0.0 109.819 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.08 14.0 66.04 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.2 48.66 1.34 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 32' ' ' THR . 1.7 m-20 -167.86 -63.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 108.842 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.88 -35.06 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -73.41 -3.76 29.34 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.207 0.527 . . . . 0.0 109.634 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.2 t -75.82 -21.71 57.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 14.7 pt-20 -105.7 -24.52 12.51 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.513 -0.742 . . . . 0.0 109.747 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -91.21 -11.93 36.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 110.623 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.2 t -48.8 -24.6 1.48 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 108.396 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.21 50.33 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 15.5 t30 -151.54 -88.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -1.176 . . . . 0.0 110.198 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.1 141.27 36.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.941 . . . . 0.0 110.631 -178.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' SER . 75.5 m -157.48 169.73 24.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.04 152.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.15 -0.969 . . . . 0.0 109.774 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -52.62 -43.31 65.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.255 -0.903 . . . . 0.0 109.045 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -42.14 91.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 4.0 t80 -62.29 -33.83 75.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.985 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.58 -42.63 96.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.589 -0.694 . . . . 0.0 109.159 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' CYS . 14.6 mmm-85 -48.3 -48.95 35.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.601 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 10.3 p -74.86 -6.34 48.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 110.204 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.759 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -24.98 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -105.14 -40.38 5.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -150.36 72.63 9.17 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.125 -0.985 . . . . 0.0 109.805 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.895 2.397 . . . . 0.0 110.402 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.778 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 148.69 31.03 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 8.1 t -77.03 -166.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.546 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -103.96 158.94 16.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.509 -0.744 . . . . 0.0 109.159 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -165.18 102.34 0.75 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.657 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -135.95 -80.79 0.41 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.576 -0.703 . . . . 0.0 109.197 -178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -57.43 -35.46 72.22 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 106.79 -2.524 . . . . 0.0 106.79 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' SER . 14.4 tpp180 -70.47 -48.01 57.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.91 -0.759 . . . . 0.0 109.019 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -56.38 -30.46 62.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 109.007 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.0 mm? -77.25 -46.42 23.18 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.336 -0.853 . . . . 0.0 109.331 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.1 tp -77.59 -17.01 14.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.7 t -76.29 -61.06 2.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.882 HD11 HD11 ' A' ' 44' ' ' ILE . 1.1 pt? -59.79 -38.46 81.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.987 -1.07 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 44' ' ' ILE . 30.9 m -73.64 -32.26 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.16 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.28 -24.26 2.8 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 120.279 -1.513 . . . . 0.0 107.597 179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -88.02 -27.37 22.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -93.33 -42.48 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.217 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 26.8 m -94.09 -22.03 18.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 54.59 32.56 53.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER 66.17 41.41 3.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -1.05 . . . . 0.0 109.25 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -112.67 -54.46 2.62 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.478 -0.764 . . . . 0.0 109.031 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -68.85 -40.05 79.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 108.887 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 1.5 t30 81.54 106.87 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.688 -0.633 . . . . 0.0 112.161 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.875 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -83.1 85.59 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.486 2.124 . . . . 0.0 109.171 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' PRO . 3.7 mt-30 -38.92 152.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -0.857 . . . . 0.0 110.559 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.17 41.34 1.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.866 . . . . 0.0 109.313 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.29 23.96 1.39 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -78.35 -163.62 0.46 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.042 0.925 . . . . 0.0 110.823 -179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.625 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.03 -32.93 0.11 Allowed 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.763 HG13 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -44.25 -37.85 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.423 -0.798 . . . . 0.0 109.06 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.605 ' HB3' ' NZ ' ' A' ' 28' ' ' LYS . . . -59.72 -13.8 11.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.818 -0.551 . . . . 0.0 109.903 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 29' ' ' ASP . 6.5 t -71.8 -19.28 62.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.119 -0.988 . . . . 0.0 109.547 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 30' ' ' ILE . 2.4 pt-20 -105.35 -19.87 13.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.402 -0.811 . . . . 0.0 109.763 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.639 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -86.82 3.74 43.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 110.321 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -45.41 -26.69 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 108.572 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.92 -55.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -1.097 . . . . 0.0 109.847 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.6 mt-30 -115.19 129.76 56.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 57.2 m -156.47 175.61 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 172.48 146.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.034 -1.041 . . . . 0.0 109.877 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.85 -44.95 86.86 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.369 -0.832 . . . . 0.0 109.617 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.92 -26.49 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.978 . . . . 0.0 108.729 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.611 ' CE2' ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -72.63 -18.46 61.58 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.999 HG12 HG12 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -75.98 -32.33 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.379 -0.826 . . . . 0.0 109.303 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.9 mmt-85 -51.6 -46.64 63.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.735 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.523 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -77.08 -6.77 54.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.062 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.763 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -103.66 -14.76 16.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.929 -1.107 . . . . 0.0 108.643 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -112.89 -35.79 5.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.61 72.79 3.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 0.0 109.793 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.6 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.802 2.334 . . . . 0.0 110.344 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.862 0 N-CA-C 119.364 2.506 . . . . 0.0 119.364 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.65 153.48 22.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.186 -1.185 . . . . 0.0 109.453 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.2 t -149.04 -163.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 1.4 ttm180 -61.73 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.581 0.705 . . . . 0.0 109.634 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 165.01 112.54 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.715 ' O ' HD23 ' A' ' 10' ' ' LEU . 69.5 m -137.2 -73.28 0.43 Allowed 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.502 -0.749 . . . . 0.0 109.406 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -53.83 -40.62 64.98 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 106.421 -2.672 . . . . 0.0 106.421 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -69.21 -48.83 60.93 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.98 -34.69 57.14 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.917 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -69.3 -50.5 46.09 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.434 -0.791 . . . . 0.0 109.345 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.8 tp -74.35 -20.4 17.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 108.798 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.4 OUTLIER -77.66 -56.79 4.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.455 -0.778 . . . . 0.0 109.335 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.763 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -61.81 -39.99 93.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.056 -1.027 . . . . 0.0 109.401 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.994 HG12 ' CG1' ' A' ' 44' ' ' ILE . 27.8 m -69.73 -36.75 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.031 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -47.7 -27.31 1.89 Allowed 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.834 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -86.76 -27.04 23.86 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -89.22 -48.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 108.48 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 45.6 m -77.51 -68.68 0.6 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.82 -21.17 20.56 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' LEU . 52.1 p30 -102.96 11.77 36.95 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.43 -1.041 . . . . 0.0 108.395 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 46.2 48.69 12.97 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.35 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.773 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.8 t30 -172.91 81.93 0.42 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.774 -1.204 . . . . 0.0 110.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' ILE . 37.0 Cg_endo -81.03 73.52 5.97 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.845 2.363 . . . . 0.0 110.328 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -54.8 168.42 0.29 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.054 -1.029 . . . . 0.0 109.528 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -121.56 68.38 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.369 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -106.54 14.98 42.35 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 44.87 50.55 8.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.141 . . . . 0.0 109.685 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.918 ' O ' HG22 ' A' ' 32' ' ' THR . 1.6 m-20 -127.45 -80.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.364 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.043 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -49.81 -34.91 9.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.092 -1.005 . . . . 0.0 108.726 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -79.39 -3.98 48.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.72 -0.613 . . . . 0.0 110.001 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.918 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.9 t -79.95 -17.7 52.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 11.5 pt-20 -105.57 -28.17 10.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.332 -0.855 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.777 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.74 5.25 25.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.213 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 m -49.69 -23.59 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.05 . . . . 0.0 108.683 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.18 48.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -159.08 -43.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -1.212 . . . . 0.0 110.131 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.448 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 2.3 mt-30 -130.78 125.61 34.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.973 -1.079 . . . . 0.0 110.559 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . 90.3 m -156.5 -175.89 5.67 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER 163.64 150.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.045 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -55.09 -42.59 73.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.406 -0.809 . . . . 0.0 109.298 179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -63.89 -46.28 85.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.12 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.521 ' HE1' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -53.81 -41.5 67.4 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.994 ' CG1' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.5 -43.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -45.21 -53.87 7.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.134 -0.979 . . . . 0.0 109.312 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -76.53 2.31 14.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.134 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.043 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.85 -27.64 9.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -100.15 -55.87 2.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 76.3 59.76 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.057 -1.027 . . . . 0.0 109.899 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.0 Cg_endo . . . . . 0 C--N 1.309 -1.519 0 C-N-CA 122.75 2.3 . . . . 0.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.845 0 N-CA-C 119.494 2.558 . . . . 0.0 119.494 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -56.34 135.63 53.75 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.111 -1.229 . . . . 0.0 109.645 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' ARG . 14.2 t -64.14 -164.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.614 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.575 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 34.44 -153.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.519 0.676 . . . . 0.0 109.896 179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.575 ' N ' ' HD3' ' A' ' 4' ' ' ARG . . . 179.45 103.44 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.603 ' O ' HD23 ' A' ' 10' ' ' LEU . 64.5 m -138.16 -73.56 0.4 Allowed 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.591 -0.693 . . . . 0.0 109.155 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -56.18 -38.54 77.68 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 106.031 -2.827 . . . . 0.0 106.031 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -73.06 -36.12 66.82 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -65.49 -31.04 71.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.737 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.9 mm? -67.76 -41.69 82.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.236 -0.915 . . . . 0.0 108.943 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -82.73 -25.03 8.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.115 -0.991 . . . . 0.0 108.773 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 57.8 m -69.38 -57.62 5.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.377 -0.827 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.833 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.51 -35.36 79.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.002 -1.061 . . . . 0.0 109.936 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.941 HG12 HG12 ' A' ' 44' ' ' ILE . 33.3 m -77.99 -31.29 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 118.445 -1.302 . . . . 0.0 109.599 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -50.87 -24.5 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.806 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.02 -23.27 18.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.96 -38.78 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.743 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.552 ' SG ' HG23 ' A' ' 17' ' ' VAL . 13.1 m -98.93 -21.2 16.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 27.12 63.14 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 67.24 58.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -1.162 . . . . 0.0 109.479 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -133.97 -52.71 0.85 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -0.825 . . . . 0.0 109.606 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -59.47 -73.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.6 OUTLIER 164.16 96.22 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.463 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.931 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.1 Cg_endo -77.92 65.02 8.31 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.523 2.149 . . . . 0.0 110.59 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.97 158.28 35.03 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.236 -0.915 . . . . 0.0 109.654 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 2.8 pt-20 -132.25 73.22 1.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -97.93 21.95 43.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 27' ' ' GLY . 2.4 tmtt? 43.74 51.23 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.503 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.811 ' O ' HG22 ' A' ' 32' ' ' THR . 35.3 m-20 -133.82 -71.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.289 -0.882 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.72 -38.86 36.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -74.43 -2.96 27.79 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.736 -0.603 . . . . 0.0 109.776 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.7 t -77.46 -19.01 56.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.398 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.37 -33.16 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.373 -0.829 . . . . 0.0 109.668 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.643 ' CB ' HD11 ' A' ' 10' ' ' LEU . 11.0 m -78.88 -14.71 59.08 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -54.03 -20.0 5.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.82 . . . . 0.0 109.217 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.49 52.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.99 -73.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -1.162 . . . . 0.0 109.602 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 mm100 -125.31 154.54 41.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.886 . . . . 0.0 109.552 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.79 145.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.68 166.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.74 -35.97 56.95 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.424 -0.798 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t0 -69.6 -49.59 52.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.06 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.591 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -49.29 -41.7 38.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 108.947 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.941 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.11 -41.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.318 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 5.3 mpt_? -44.7 -52.67 8.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.73 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -75.25 -5.65 45.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.706 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.4 -23.87 13.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 108.274 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -107.92 -35.71 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -153.45 71.57 6.81 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 109.865 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 33.1 Cg_endo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.846 2.364 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.821 0 N-CA-C 119.345 2.498 . . . . 0.0 119.345 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.72 117.22 2.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.169 -1.195 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 4.9 t -135.27 -166.85 1.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' N ' ' OG1' ' A' ' 3' ' ' THR . 2.1 tpp180 -114.86 149.96 36.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 109.533 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' LYS . . . -109.19 82.54 1.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.1 m -135.4 -76.01 0.45 Allowed 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.06 -41.38 85.25 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 10.5 tpp180 -72.21 -41.3 67.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 40.4 tttt -58.54 -31.93 68.4 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -69.26 -47.2 65.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.207 -0.933 . . . . 0.0 108.819 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.5 tp -76.52 -15.02 14.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 108.781 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.89 -62.0 1.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.33 -0.856 . . . . 0.0 109.803 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.751 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -59.93 -34.76 73.66 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.881 -1.137 . . . . 0.0 109.821 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.0 HG12 HG12 ' A' ' 44' ' ' ILE . 34.6 m -75.73 -33.27 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.599 -1.24 . . . . 0.0 109.757 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.545 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -49.74 -24.83 2.53 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.612 -1.305 . . . . 0.0 107.956 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.31 -24.56 19.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.11 -39.01 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.833 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.0 m -98.21 -29.51 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.732 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.16 24.96 53.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 61.34 46.45 7.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -1.129 . . . . 0.0 109.562 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD13 ' O ' ' A' ' 21' ' ' LEU . 3.3 tm? -129.71 -34.66 1.74 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -59.32 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.666 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER 165.85 96.34 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.12 . . . . 0.0 110.189 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.863 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.2 Cg_endo -78.64 64.46 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.595 2.196 . . . . 0.0 109.936 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -63.28 151.14 41.46 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 110.102 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.93 49.0 1.54 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.333 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' ASP . . . -83.82 50.89 4.48 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -27.54 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.912 0.863 . . . . 0.0 110.939 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.912 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -167.62 -67.77 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -50.42 -34.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -76.8 -10.17 59.19 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.26 0.552 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.9 t -78.85 -20.6 49.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -105.96 -19.43 13.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.734 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.7 m -93.96 -1.12 55.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.185 -0.947 . . . . 0.0 109.883 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.36 -20.73 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.126 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.58 38.43 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -139.57 -58.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -1.173 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 3.2 mt-30 -127.04 134.21 50.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.27 148.21 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 109.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.75 163.99 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -52.43 -37.29 56.47 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 35.4 t0 -66.39 -47.17 74.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 30' ' ' ILE . 1.2 t80 -51.69 -43.76 62.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.873 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.0 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.18 -39.3 12.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 121.732 -0.605 . . . . 0.0 109.545 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -45.3 -55.72 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.642 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.544 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.4 m -77.2 0.05 23.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.177 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.802 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -105.72 -23.68 12.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.61 -48.03 3.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 45' ' ' ARG . 22.1 m -136.37 70.62 60.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.064 -1.023 . . . . 0.0 110.219 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.567 0 C-N-CA 122.681 2.254 . . . . 0.0 110.405 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.912 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.18 146.44 38.98 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -1.117 . . . . 0.0 109.644 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -104.48 -164.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.356 -0.84 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -57.13 150.55 17.18 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.136 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.817 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . -132.1 87.96 2.5 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.662 ' O ' HD23 ' A' ' 10' ' ' LEU . 5.4 t -137.04 -80.66 0.38 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.179 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . -49.9 -43.1 39.26 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -67.37 -57.53 6.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.817 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 1.1 mmmt -40.31 -37.15 0.62 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.371 0.605 . . . . 0.0 109.741 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.2 mm? -71.19 -50.75 29.84 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.577 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.5 tp -77.87 -14.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 109.035 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.544 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -76.05 -60.29 2.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 109.677 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.758 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.49 -34.52 74.18 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.878 -1.139 . . . . 0.0 109.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.903 HG12 HG12 ' A' ' 44' ' ' ILE . 28.9 m -77.68 -30.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.717 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.56 -24.62 3.35 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.525 -1.359 . . . . 0.0 107.819 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.97 -25.11 19.02 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.27 -39.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' A' ' 17' ' ' VAL . 4.1 m -102.66 -42.1 6.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.519 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 98.38 36.93 4.45 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 19' ' ' GLY . 1.5 p-10 41.23 56.33 3.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.395 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -141.99 -37.43 0.4 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.862 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -51.35 -74.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 109.299 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.4 m-20 163.59 88.69 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.942 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.0 Cg_endo -79.47 45.37 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.567 2.178 . . . . 0.0 110.281 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' GLU . 3.3 mt-30 -79.32 159.5 27.16 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.31 -0.869 . . . . 0.0 109.699 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER 42.99 70.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.53 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.22 2.32 68.3 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -94.63 48.24 1.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.162 -1.199 . . . . 0.0 110.074 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 32' ' ' THR . 4.4 m-20 -158.29 -71.01 0.09 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.666 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -53.12 -33.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -67.94 -11.61 59.1 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.2 t -67.45 -15.02 63.44 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.379 -0.825 . . . . 0.0 109.3 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.8 pt-20 -104.8 -64.32 1.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.796 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.7 m -41.65 -28.15 0.13 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -48.68 -43.37 36.87 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.814 0.816 . . . . 0.0 108.802 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.22 -51.2 0.02 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 3.2 t-20 -60.52 -16.28 35.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -1.093 . . . . 0.0 108.643 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 6.1 mt-30 77.01 -161.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.5 -0.75 . . . . 0.0 109.994 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 43' ' ' TYR . 59.9 m -153.35 -145.48 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.543 -0.723 . . . . 0.0 109.382 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.68 157.83 40.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.94 -38.82 57.85 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.119 -0.988 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.7 -47.2 61.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -46.06 -39.31 9.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.903 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.79 -41.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.088 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.6 -54.85 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -76.17 2.4 13.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.932 . . . . 0.0 110.305 -179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.666 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -110.26 -25.05 10.34 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -98.89 -50.11 4.31 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -147.53 75.25 11.32 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.009 -1.057 . . . . 0.0 110.065 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.4 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.853 2.368 . . . . 0.0 110.316 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.792 0 N-CA-C 119.441 2.536 . . . . 0.0 119.441 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.61 156.85 15.65 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.155 -1.203 . . . . 0.0 109.488 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 4' ' ' ARG . 11.4 t -142.13 -161.76 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.684 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -124.31 -162.03 1.04 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.738 0.78 . . . . 0.0 109.647 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 169.82 117.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.697 ' O ' HD23 ' A' ' 10' ' ' LEU . 1.8 t -134.84 -68.62 0.53 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -55.34 -41.88 81.2 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 105.723 -2.951 . . . . 0.0 105.723 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' SER . 5.9 mmt180 -71.91 -45.31 61.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.816 ' O ' HD22 ' A' ' 13' ' ' LEU . 1.3 mmmt -50.71 -33.62 23.57 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.267 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -75.43 -49.04 20.11 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.418 -0.801 . . . . 0.0 109.81 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.9 tp -79.32 -14.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 108.932 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 8' ' ' ARG . 4.9 m -82.18 -56.53 3.87 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.417 -0.802 . . . . 0.0 109.354 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.976 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -61.4 -37.22 82.64 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.065 -1.022 . . . . 0.0 109.402 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.011 HG12 HG12 ' A' ' 44' ' ' ILE . 30.1 m -71.87 -38.83 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.066 -1.021 . . . . 0.0 109.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.2 ppp? -46.84 -26.91 1.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.766 -1.174 . . . . 0.0 108.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.72 -23.84 17.38 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -91.63 -37.93 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.985 . . . . 0.0 108.903 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 83.4 m -81.94 -62.76 1.54 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.66 -20.17 24.99 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' LEU . 10.1 p30 -108.48 9.22 27.57 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.418 -1.048 . . . . 0.0 108.581 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 45.2 45.63 9.54 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -30.9 -73.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.974 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' CYS . 2.3 t30 -177.64 99.93 0.22 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HB3' HD13 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -79.81 92.07 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.659 2.239 . . . . 0.0 110.259 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 11.9 mm-40 -60.29 134.58 57.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.237 -0.915 . . . . 0.0 109.67 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -101.53 51.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 9.8 51.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.42 57.39 6.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.924 ' O ' HG22 ' A' ' 32' ' ' THR . 31.5 m-20 -131.48 -71.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.764 HG21 ' O ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -52.79 -38.32 27.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.044 -1.035 . . . . 0.0 109.009 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -76.11 -6.26 50.39 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.857 -0.527 . . . . 0.0 109.961 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.1 t -77.8 -19.84 54.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.944 -1.098 . . . . 0.0 109.63 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -106.52 -23.07 12.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 110.565 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.775 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.9 m -86.56 -0.04 55.32 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.074 . . . . 0.0 110.648 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 -23.6 6.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.061 . . . . 0.0 108.843 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.36 39.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -140.86 -68.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.148 . . . . 0.0 109.526 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -112.08 139.53 47.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.5 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.66 137.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 109.138 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -170.87 163.93 7.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.68 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -48.73 -37.13 17.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.404 -0.81 . . . . 0.0 109.717 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.4 t0 -69.48 -53.38 19.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.234 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CE1' ' SG ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -49.68 -38.95 34.83 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.011 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.42 -41.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.765 -0.584 . . . . 0.0 109.558 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.6 OUTLIER -43.44 -54.59 4.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.325 -0.859 . . . . 0.0 109.478 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.764 ' O ' HG21 ' A' ' 30' ' ' ILE . 14.8 m -75.44 2.98 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.72 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -108.91 -28.74 8.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -99.07 -48.88 4.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.45 76.85 15.84 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.004 . . . . 0.0 110.149 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.7 Cg_endo . . . . . 0 C--N 1.31 -1.468 0 C-N-CA 122.879 2.386 . . . . 0.0 110.336 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.841 0 N-CA-C 119.359 2.504 . . . . 0.0 119.359 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.65 154.46 6.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.281 -1.129 . . . . 0.0 109.578 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 2.2 t -125.54 -168.3 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.785 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -108.51 143.47 37.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.447 -0.783 . . . . 0.0 109.862 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 4' ' ' ARG . . . -107.02 82.67 1.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 18.6 t -136.76 -76.36 0.42 Allowed 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.523 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -48.49 -42.21 26.38 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 106.676 -2.57 . . . . 0.0 106.676 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -69.57 -55.45 10.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HG3' HD22 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -53.15 -29.2 30.03 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 13' ' ' LEU . 1.3 mm? -65.66 -37.29 86.11 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.184 -0.948 . . . . 0.0 108.797 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -85.63 -25.19 6.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 108.72 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.55 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -70.25 -50.06 43.62 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.45 -0.781 . . . . 0.0 109.14 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.51 -44.55 90.54 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.934 -1.104 . . . . 0.0 109.226 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 35.1 m -69.02 -32.99 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.4 ppp? -50.21 -24.93 3.15 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.415 -1.314 . . . . 0.0 107.757 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.39 -25.15 21.71 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.1 m -91.28 -35.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.808 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' A' ' 17' ' ' VAL . 3.8 m -103.2 -19.11 14.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.606 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.43 33.24 61.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t0 61.86 42.73 10.1 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.419 -1.048 . . . . 0.0 109.231 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.9 tm? -119.43 -47.98 2.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.745 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -64.1 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.06 -1.025 . . . . 0.0 109.498 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.1 m-20 163.37 100.48 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.635 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.7 Cg_endo -78.5 48.42 2.73 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.377 2.052 . . . . 0.0 110.371 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 24.5 mt-30 -76.36 -173.28 2.41 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 109.659 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 1.4 pm0 31.07 69.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.287 0.565 . . . . 0.0 110.632 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.54 -22.94 52.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 50.47 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -1.221 . . . . 0.0 109.727 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -159.16 -74.89 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 108.912 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.063 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.28 -37.96 18.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.24 -0.912 . . . . 0.0 108.666 179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.674 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -67.45 -10.8 54.83 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.8 t -68.93 -17.95 64.03 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 109.398 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 30' ' ' ILE . 1.6 pt-20 -105.9 -30.55 9.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -78.26 -11.48 59.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 111.088 -179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 95.2 m -54.05 -20.09 5.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.813 -1.179 . . . . 0.0 108.866 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.75 49.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -146.56 -52.76 0.23 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.333 -1.098 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 1.9 mt-30 -150.89 144.43 24.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.255 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 93.0 m -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 168.52 154.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.827 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.2 -42.84 52.11 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.252 -0.905 . . . . 0.0 108.903 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -60.57 -46.26 90.87 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 9.8 t80 -54.35 -38.94 66.65 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.68 -31.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 49' ' ' CYS . 1.7 tpt180 -50.78 -56.57 11.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -76.51 -3.96 40.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.988 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.063 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -100.29 -25.78 14.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -111.1 -45.29 3.45 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -135.75 68.33 65.42 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.921 -1.112 . . . . 0.0 110.058 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.752 2.301 . . . . 0.0 110.383 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.15 136.98 42.89 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.305 -1.115 . . . . 0.0 109.677 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.7 t -157.9 -165.04 1.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.638 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -98.69 -148.22 0.33 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.698 0.761 . . . . 0.0 109.349 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 163.64 115.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 10' ' ' LEU . 62.1 m -136.49 -72.59 0.44 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -53.55 -44.86 67.99 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 2.1 tpp85 -69.8 -45.66 67.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' CB ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -48.52 -37.72 18.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.596 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.815 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.2 mm? -72.38 -51.6 19.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.379 -0.826 . . . . 0.0 109.699 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -72.98 -15.28 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 108.715 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 7.5 t -76.77 -64.21 1.18 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.765 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -58.31 -34.19 70.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.901 -1.124 . . . . 0.0 109.607 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 23.1 m -77.32 -31.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.41 -24.15 2.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.409 -1.432 . . . . 0.0 107.751 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.99 -25.05 19.03 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.03 -40.37 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.86 . . . . 0.0 109.775 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.6 m -100.96 -41.49 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 88.4 35.19 8.83 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 50.77 52.19 15.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -1.115 . . . . 0.0 109.279 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.886 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.35 -41.72 0.98 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.315 -0.865 . . . . 0.0 109.814 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -57.49 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.475 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.5 t30 172.41 92.32 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.186 -0.947 . . . . 0.0 109.61 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.89 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.8 Cg_endo -78.54 65.06 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 23' ' ' ASN . 6.9 mt-30 -56.26 168.08 0.58 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -133.33 59.14 1.74 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.25 7.85 77.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 2.9 tmtt? 47.4 66.04 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.156 . . . . 0.0 109.563 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.898 ' O ' HG22 ' A' ' 32' ' ' THR . 1.1 m-20 -146.49 -75.55 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 109.208 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.63 -34.23 8.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.052 -1.03 . . . . 0.0 108.675 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -78.4 -5.94 53.77 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.174 0.512 . . . . 0.0 109.889 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.6 t -78.38 -20.49 51.12 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 10.9 pt-20 -106.19 -21.86 13.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' CB ' HD11 ' A' ' 10' ' ' LEU . 3.4 m -86.28 2.21 48.09 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 110.238 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -49.44 -24.11 1.84 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.04 -1.038 . . . . 0.0 108.924 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.47 46.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -154.92 -37.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 66.8 mt-30 -136.71 120.16 17.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 109.502 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.17 147.24 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.316 -0.865 . . . . 0.0 109.167 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.56 165.25 12.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.77 -37.37 65.92 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.306 -0.871 . . . . 0.0 109.219 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -67.79 -48.45 66.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.011 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.686 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -52.54 -40.92 63.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 108.781 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.47 -46.86 36.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 44' ' ' ILE . 5.4 mmm180 -43.84 -55.19 4.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.833 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.591 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 29.8 t -76.48 2.62 13.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 110.206 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.841 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -110.14 -23.91 11.01 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.14 -49.91 4.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.31 75.44 11.45 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.948 -1.095 . . . . 0.0 110.158 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 122.883 2.389 . . . . 0.0 110.447 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.812 0 N-CA-C 119.497 2.559 . . . . 0.0 119.497 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -68.16 162.46 24.78 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.232 -1.158 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.2 t -125.68 -161.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.5 tmt_? -52.95 148.67 7.4 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.507 0.67 . . . . 0.0 109.343 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -157.7 98.28 1.64 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.535 ' O ' HD23 ' A' ' 10' ' ' LEU . 85.2 m -137.92 -75.39 0.4 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.277 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -50.6 -42.79 45.0 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -68.19 -53.91 21.58 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -34.11 11.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 1.6 mm? -61.79 -46.11 90.95 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.102 -0.999 . . . . 0.0 109.414 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.6 tp -79.61 -19.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.096 -1.003 . . . . 0.0 108.77 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.512 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -78.89 -54.56 5.93 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.515 -0.741 . . . . 0.0 109.437 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.97 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -61.32 -36.75 80.99 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.191 -0.943 . . . . 0.0 109.254 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.042 HG12 HG12 ' A' ' 44' ' ' ILE . 21.7 m -73.1 -38.51 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 109.289 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.15 -25.56 1.53 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.416 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.52 -23.47 17.67 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.97 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -91.17 -37.38 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.168 -0.958 . . . . 0.0 109.024 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 57.7 m -84.81 -60.76 1.96 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.5 24.31 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.4 p30 -108.83 10.32 26.61 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.464 -1.021 . . . . 0.0 108.696 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 44.82 50.83 8.69 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 48' ' ' CYS . 11.2 t -32.41 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 44.7 t30 -179.1 96.07 0.2 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.851 -1.155 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 35.5 Cg_endo -78.15 84.79 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.521 2.147 . . . . 0.0 109.997 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -58.29 166.83 1.52 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.366 -0.834 . . . . 0.0 109.866 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -117.69 65.41 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.641 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -107.63 7.34 36.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER 43.07 51.97 5.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -1.131 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.961 ' O ' HG22 ' A' ' 32' ' ' THR . 6.9 m-20 -130.16 -58.55 1.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -59.67 -38.5 76.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.119 -0.988 . . . . 0.0 109.414 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -80.54 -2.98 48.46 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 109.977 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.961 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.7 t -76.83 -21.77 54.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.992 -1.067 . . . . 0.0 108.904 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 43' ' ' TYR . 4.9 pt-20 -105.66 -29.71 9.93 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.525 -0.734 . . . . 0.0 109.403 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.768 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -86.85 -9.89 54.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 43.3 t -47.73 -25.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 108.777 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.9 51.18 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -155.38 -75.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -1.173 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 16.4 tt0 -114.61 147.52 39.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.178 -0.951 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 55.0 m -158.55 178.78 9.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 169.02 143.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.974 -1.078 . . . . 0.0 109.908 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.5 m-20 -51.7 -46.43 63.87 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.321 -0.862 . . . . 0.0 108.709 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 3.1 m-20 -59.84 -43.11 94.78 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' OE2' ' A' ' 33' ' ' GLU . 1.2 t80 -55.14 -36.91 66.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.0 108.659 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.042 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.91 -36.89 31.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 109.47 -179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -43.49 -51.9 6.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 0.0 109.851 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -75.98 -3.09 33.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.31 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.914 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -102.73 -25.3 13.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -110.1 -52.42 2.78 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ARG . 4.2 m -128.12 69.73 77.84 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 110.64 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.307 -1.651 0 C-N-CA 122.717 2.278 . . . . 0.0 110.186 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.846 0 N-CA-C 119.425 2.53 . . . . 0.0 119.425 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.56 139.64 39.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -1.132 . . . . 0.0 109.193 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 3.9 t -63.45 -168.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.701 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' N ' ' OG1' ' A' ' 3' ' ' THR . 6.0 tpp180 -115.65 149.73 37.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -0.762 . . . . 0.0 109.319 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.57 ' HB1' ' HG2' ' A' ' 9' ' ' LYS . . . -120.44 80.85 1.67 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 1.8 m -137.83 -81.6 0.34 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.188 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . -57.36 -41.17 92.98 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' CD ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.1 -51.45 61.27 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.57 ' HG2' ' HB1' ' A' ' 5' ' ' ALA . 3.0 mmmt -40.81 -43.34 2.0 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.514 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.932 HD11 ' CB ' ' A' ' 34' ' ' CYS . 3.0 mm? -60.72 -50.93 71.5 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.398 -0.814 . . . . 0.0 109.555 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.845 HD13 ' HG3' ' A' ' 24' ' ' PRO . 1.5 tp -78.03 -22.02 13.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -71.39 -59.88 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -0.803 . . . . 0.0 109.77 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.939 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -60.89 -33.08 72.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.055 -1.028 . . . . 0.0 109.901 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG12 HG12 ' A' ' 44' ' ' ILE . 29.0 m -79.71 -30.68 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.678 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -52.33 -23.04 5.19 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.589 -1.32 . . . . 0.0 107.855 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -96.42 -21.22 17.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -94.47 -37.56 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.485 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 22' ' ' CYS . 21.4 m -99.0 -25.02 14.7 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.97 44.02 98.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' OD2' ' A' ' 20' ' ' ASP . 21.3 t70 52.01 46.84 25.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -1.137 . . . . 0.0 109.169 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.877 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 tm? -124.78 -42.6 2.05 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.373 -0.829 . . . . 0.0 109.518 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.614 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -72.06 -32.02 66.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 109.717 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER 84.19 114.41 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.755 -0.591 . . . . 0.0 109.853 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.845 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -79.48 98.56 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.394 2.063 . . . . 0.0 110.223 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 50' ' ' PRO . 28.1 mm-40 -44.16 156.84 0.06 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.31 -0.869 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -114.63 56.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 109.681 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.57 -4.0 58.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.45 62.63 2.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -1.165 . . . . 0.0 109.502 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.864 ' O ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER -153.04 -47.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -56.58 -37.39 51.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.173 -0.955 . . . . 0.0 109.398 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -76.5 -2.99 34.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.522 -0.736 . . . . 0.0 109.834 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.1 t -74.87 -19.25 60.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.041 -1.037 . . . . 0.0 109.234 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.0 pt-20 -105.17 -37.78 6.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.405 -0.809 . . . . 0.0 109.614 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.932 ' CB ' HD11 ' A' ' 10' ' ' LEU . 20.1 m -75.19 -21.65 58.57 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.53 -23.2 9.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.358 -0.839 . . . . 0.0 108.871 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.84 36.87 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLU . 9.0 t30 -135.52 -69.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -1.17 . . . . 0.0 109.413 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -134.59 156.92 47.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.98 153.82 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.51 162.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.563 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.3 m-20 -52.94 -37.53 61.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.284 -0.885 . . . . 0.0 109.256 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.3 t70 -69.34 -45.52 69.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.319 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.627 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -48.54 -48.09 38.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.073 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HG12 HG12 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -46.5 -37.85 3.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.6 OUTLIER -44.58 -53.31 7.24 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.69 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 8.0 t -75.72 -8.92 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -99.11 -22.95 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.007 . . . . 0.0 108.302 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -111.07 -43.92 3.67 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' ARG . 20.2 m -141.0 70.09 28.76 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.001 -1.062 . . . . 0.0 109.958 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 C-N-CA 122.875 2.383 . . . . 0.0 110.405 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.876 0 N-CA-C 119.45 2.54 . . . . 0.0 119.45 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 2' ' ' GLU . 5.8 pt-20 -63.76 127.68 32.44 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.29 -1.124 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.4 t -152.5 -165.65 2.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.5 tpp180 -91.68 156.02 17.89 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.567 -0.708 . . . . 0.0 109.334 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -144.93 97.61 3.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.647 ' O ' HD23 ' A' ' 10' ' ' LEU . 21.7 m -135.47 -72.68 0.46 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.62 -41.83 99.77 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.65 -2.58 . . . . 0.0 106.65 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HD3' HG23 ' A' ' 11' ' ' ILE . 3.9 tpp85 -70.71 -36.82 73.42 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -59.31 -35.53 73.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.602 -0.686 . . . . 0.0 109.559 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.794 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.6 mm? -66.84 -45.62 77.65 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.103 -0.998 . . . . 0.0 109.08 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -80.92 -18.56 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.941 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 15' ' ' MET . 2.8 t -76.3 -57.44 3.86 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.794 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -61.36 -34.72 75.78 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.939 HG12 HG12 ' A' ' 44' ' ' ILE . 34.4 m -77.59 -31.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.471 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -51.05 -24.15 3.61 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.508 -1.37 . . . . 0.0 107.873 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.81 -23.95 18.67 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.1 m -90.56 -38.17 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.361 -0.837 . . . . 0.0 109.234 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -100.96 -44.28 5.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.855 . . . . 0.0 109.214 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 74.7 56.01 5.17 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 43.72 49.29 6.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -1.082 . . . . 0.0 109.19 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -129.47 -47.96 1.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.0 109.733 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -64.38 -81.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.685 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 170.99 97.93 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 0.0 109.506 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.861 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -77.73 68.76 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.505 2.137 . . . . 0.0 110.482 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' CD ' ' HG2' ' A' ' 50' ' ' PRO . 1.5 mt-30 -61.69 142.21 57.35 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.333 -0.854 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.3 64.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.455 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.1 15.83 60.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.69 61.19 2.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -1.121 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.832 ' O ' HG22 ' A' ' 32' ' ' THR . 2.4 m-20 -141.0 -65.39 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.974 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -56.34 -40.92 69.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -71.65 -3.01 19.24 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.589 -0.695 . . . . 0.0 109.821 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.0 t -75.9 -20.59 57.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.114 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 4.8 pt-20 -105.57 -35.66 7.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.498 -0.751 . . . . 0.0 109.808 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.794 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -75.58 -16.05 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.8 -24.11 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.008 . . . . 0.0 108.722 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.53 39.91 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.03 -47.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -1.147 . . . . 0.0 109.702 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.46 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 30.5 mt-30 -157.45 153.85 27.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.124 -0.985 . . . . 0.0 110.199 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 40' ' ' SER . 64.9 m -157.24 177.01 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.458 -0.776 . . . . 0.0 108.969 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER 163.96 143.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.639 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -44.9 61.22 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.251 -0.905 . . . . 0.0 108.826 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 m-20 -59.26 -40.07 84.84 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.939 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -61.95 -33.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -52.1 -45.61 64.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 66.9 m -74.47 -8.13 55.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.019 -1.051 . . . . 0.0 110.101 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.974 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.37 -21.87 13.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.999 -1.063 . . . . 0.0 108.435 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -113.5 -45.05 3.15 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 6.9 m -136.78 67.44 57.68 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.968 -1.082 . . . . 0.0 110.381 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.307 -1.627 0 C-N-CA 122.719 2.279 . . . . 0.0 110.395 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.87 0 N-CA-C 119.387 2.515 . . . . 0.0 119.387 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -63.92 -177.63 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.218 -1.166 . . . . 0.0 109.699 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.497 ' O ' ' C ' ' A' ' 4' ' ' ARG . 6.9 t -126.82 -165.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 33.2 -140.17 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.489 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 166.36 110.85 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.604 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.7 m -136.9 -86.32 0.32 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.571 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -49.86 -41.24 35.85 Favored Glycine 0 N--CA 1.482 1.767 0 N-CA-C 106.52 -2.632 . . . . 0.0 106.52 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -65.94 -59.1 4.17 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -47.61 -34.44 7.91 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.624 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.942 HD11 ' CB ' ' A' ' 34' ' ' CYS . 2.3 mm? -66.0 -53.74 34.92 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.896 -1.127 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.925 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.6 tp -77.82 -13.56 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.243 -0.911 . . . . 0.0 109.04 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.5 OUTLIER -77.23 -60.43 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.695 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.1 pt? -60.64 -34.28 74.04 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.982 -1.073 . . . . 0.0 109.731 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.018 HG12 HG12 ' A' ' 44' ' ' ILE . 33.9 m -77.0 -32.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.64 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.539 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -50.44 -24.56 3.18 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.519 -1.363 . . . . 0.0 107.926 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.87 -24.42 19.34 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.86 -38.02 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.403 -0.81 . . . . 0.0 109.41 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.595 ' SG ' HG23 ' A' ' 17' ' ' VAL . 5.5 m -101.06 -44.27 5.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 84.59 43.99 6.66 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 t0 48.96 47.72 21.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -1.09 . . . . 0.0 109.334 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.8 tm? -130.57 -40.42 1.24 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -60.74 -82.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.447 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER 173.24 95.15 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.63 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.925 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.54 72.98 6.1 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.467 2.112 . . . . 0.0 110.156 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -64.67 159.03 22.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.288 -0.882 . . . . 0.0 109.668 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 1.1 pm0 -125.88 64.52 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 8.37 68.68 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 46.72 53.42 10.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.422 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER -142.37 -64.8 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.518 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -51.35 -34.24 14.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.139 -0.975 . . . . 0.0 109.042 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -79.18 -4.37 50.19 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.677 -0.639 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.0 t -74.89 -16.79 60.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.118 -0.989 . . . . 0.0 109.042 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' OE2' ' CE1' ' A' ' 43' ' ' TYR . 6.4 pt-20 -105.41 -37.06 6.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.654 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.942 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -66.89 -13.11 61.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.63 -26.73 3.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 108.671 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.38 42.47 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -140.98 -50.24 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 29.3 mt-30 -142.62 144.25 32.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 38' ' ' GLN . 0.7 OUTLIER 163.31 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' CYS . 6.7 p 171.67 165.97 0.09 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.96 -36.55 28.47 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.229 -0.92 . . . . 0.0 109.307 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' TYR . 4.6 m-20 -68.76 -50.45 50.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.57 ' CE2' ' SG ' ' A' ' 34' ' ' CYS . 1.2 t80 -44.73 -40.26 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.299 -0.876 . . . . 0.0 108.906 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.018 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.2 -41.9 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -52.13 -44.02 64.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 109.702 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.56 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 47.1 m -75.42 -9.19 58.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.04 . . . . 0.0 109.853 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -103.26 -21.6 13.83 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -109.54 -47.76 3.33 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' ARG . 21.2 m -139.0 70.62 41.94 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 110.331 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 C-N-CA 122.707 2.272 . . . . 0.0 110.471 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.902 0 N-CA-C 119.491 2.556 . . . . 0.0 119.491 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.71 140.26 24.15 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.115 -1.226 . . . . 0.0 109.431 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 10.1 t -136.1 -164.81 1.61 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 109.65 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' NH2' ' SG ' ' A' ' 35' ' ' CYS . 2.3 tpp85 -84.87 154.42 22.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -131.34 91.03 2.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.1 m -136.13 -58.43 0.75 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -65.28 -39.79 96.19 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 106.255 -2.738 . . . . 0.0 106.255 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CD ' ' OG ' ' A' ' 12' ' ' SER . 9.6 tpp85 -71.04 -36.73 72.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 0.9 OUTLIER -54.14 -39.01 66.11 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -66.37 -49.08 68.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 tp -76.08 -20.68 15.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.818 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 15' ' ' MET . 4.5 m -79.52 -53.57 6.74 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.331 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -63.05 -39.42 94.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.94 -1.1 . . . . 0.0 109.143 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.028 HG12 HG12 ' A' ' 44' ' ' ILE . 31.3 m -69.72 -37.13 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.761 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.532 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.2 ppp? -48.14 -25.9 1.66 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.701 -1.199 . . . . 0.0 107.786 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -87.7 -27.86 22.15 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -84.89 -48.19 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 13.1 m -81.85 -69.64 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 89.78 -25.9 10.64 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 21' ' ' LEU . 3.7 m-20 -104.06 19.32 20.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' CD1' ' CD ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 46.55 53.2 10.17 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 1.3 t -26.23 -72.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.026 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 171.92 78.2 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.89 -1.131 . . . . 0.0 110.759 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.584 ' CD ' ' CD1' ' A' ' 21' ' ' LEU . 36.0 Cg_endo -79.33 98.47 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.553 2.168 . . . . 0.0 109.143 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 26' ' ' GLU . 54.2 mt-30 -84.01 43.87 0.96 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.102 -0.999 . . . . 0.0 110.649 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.551 ' C ' ' O ' ' A' ' 25' ' ' GLN . 5.7 pt-20 22.11 57.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.269 0.557 . . . . 0.0 111.074 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -71.74 -2.37 50.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.98 46.82 9.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.103 -1.234 . . . . 0.0 109.244 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.914 ' O ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER -147.31 -55.11 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.505 -0.747 . . . . 0.0 109.192 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' HB ' ' OH ' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -55.45 -37.74 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.181 -0.949 . . . . 0.0 109.105 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -78.69 -2.78 40.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.645 -0.659 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.914 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.4 t -79.24 -17.89 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.567 ' OE2' ' CD2' ' A' ' 43' ' ' TYR . 13.9 pt-20 -105.42 -47.39 3.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.88 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' CB ' HD11 ' A' ' 10' ' ' LEU . 85.1 m -68.31 -15.75 63.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.231 -0.918 . . . . 0.0 109.905 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' NH2' ' A' ' 4' ' ' ARG . 15.8 t -50.84 -23.11 2.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 108.676 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.9 43.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 4.6 t-20 -143.41 -76.77 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -1.155 . . . . 0.0 109.817 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -125.49 169.86 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.868 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 174.18 172.24 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.25 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.66 159.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.425 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 1.8 m-20 -58.97 -38.06 78.22 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.178 -0.951 . . . . 0.0 109.259 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.67 -43.71 83.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 108.998 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.567 ' CD2' ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -56.65 -25.48 53.68 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.028 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -43.74 99.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.581 -0.7 . . . . 0.0 109.461 -179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' CYS . 2.9 mmm180 -44.34 -49.7 9.41 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.77 -6.17 47.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 0.0 110.241 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 44' ' ' ILE . . . -102.55 -26.71 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.86 -46.02 5.26 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' ARG . 15.4 m -146.61 75.83 12.06 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.1 . . . . 0.0 109.978 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 32.5 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 122.827 2.351 . . . . 0.0 110.41 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.839 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.77 162.89 1.57 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -1.118 . . . . 0.0 109.731 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 4' ' ' ARG . 7.9 t -152.39 -164.7 2.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 5' ' ' ALA . 10.7 tpp180 -93.27 156.47 16.79 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.602 0.715 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 4' ' ' ARG . . . -118.45 98.01 6.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.673 ' O ' HD23 ' A' ' 10' ' ' LEU . 50.5 t -134.88 -91.59 0.32 Allowed 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.132 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.44 87.58 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.81 -52.08 53.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 43.3 tttm -48.08 -37.3 14.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.724 -0.61 . . . . 0.0 109.478 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.822 HD11 ' HB2' ' A' ' 34' ' ' CYS . 3.1 mm? -59.94 -52.82 63.76 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.248 -0.908 . . . . 0.0 109.156 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.916 HD13 ' HB3' ' A' ' 24' ' ' PRO . 2.1 tp -77.49 -18.54 14.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -75.49 -59.64 2.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.778 -179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.748 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -59.83 -34.62 73.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.905 -1.122 . . . . 0.0 109.471 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.058 HG12 HG12 ' A' ' 44' ' ' ILE . 32.9 m -77.0 -31.41 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.294 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.546 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.52 -24.78 2.25 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.552 -1.259 . . . . 0.0 107.962 179.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -92.4 -24.79 18.75 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.18 -39.63 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.473 -0.767 . . . . 0.0 109.694 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -100.68 -28.68 12.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 77.34 25.43 63.59 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 48.0 m-20 60.4 54.55 3.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.372 -1.076 . . . . 0.0 109.213 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -136.26 -42.76 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.198 -0.939 . . . . 0.0 110.038 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -55.72 -72.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER 164.1 96.28 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.108 -0.995 . . . . 0.0 109.85 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.916 ' HB3' HD13 ' A' ' 11' ' ' ILE . 34.8 Cg_endo -77.86 67.87 7.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.396 2.064 . . . . 0.0 109.95 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -67.82 164.33 19.84 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 67.15 1.15 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.71 5.41 78.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 45.74 66.27 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -1.136 . . . . 0.0 109.695 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.731 ' O ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -161.34 -61.84 0.05 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.293 -0.879 . . . . 0.0 109.21 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -53.63 -37.3 30.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.241 -0.912 . . . . 0.0 109.028 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -67.8 -15.31 63.57 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.731 HG22 ' O ' ' A' ' 29' ' ' ASP . 2.4 t -61.51 -14.64 31.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.013 -1.055 . . . . 0.0 109.276 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 37' ' ' ASN . 1.6 pt-20 -106.77 -69.9 0.82 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.341 -0.849 . . . . 0.0 109.259 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.822 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.5 m -35.77 -35.53 0.06 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.417 0.627 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 31' ' ' ALA . 73.8 m -67.83 -45.31 75.03 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.922 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLU . . . -128.72 -44.18 0.21 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' HB3' ' CB ' ' A' ' 33' ' ' GLU . 25.0 t-20 -77.03 -15.68 59.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 13.0 mt-30 68.41 178.23 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.629 ' HB3' ' CG ' ' A' ' 43' ' ' TYR . 3.8 m -152.15 -153.42 0.48 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.194 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 p -149.46 161.07 42.84 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.56 -23.09 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.059 -1.026 . . . . 0.0 110.005 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.14 -59.16 2.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.4 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -46.76 -30.11 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 108.639 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.058 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -55.59 -34.93 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -48.39 75.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.571 -0.705 . . . . 0.0 109.499 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.67 -7.3 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.767 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -103.58 -25.43 13.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -100.19 -42.5 6.66 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.43 75.24 6.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.983 -1.073 . . . . 0.0 109.973 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.7 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.825 2.35 . . . . 0.0 110.31 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.789 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -176.62 0.05 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 4' ' ' ARG . 15.4 t -154.18 -164.8 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.689 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 33.08 -152.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.624 0.726 . . . . 0.0 110.306 179.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 4' ' ' ARG . . . 160.27 112.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' HD23 ' A' ' 10' ' ' LEU . 14.4 m -137.19 -82.37 0.36 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 11' ' ' ILE . . . -50.21 -40.28 36.78 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' HD2' ' OG ' ' A' ' 12' ' ' SER . 11.8 tpp85 -71.19 -44.77 64.77 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.63 -28.83 69.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.514 -0.741 . . . . 0.0 109.185 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.3 mm? -72.71 -43.92 62.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.198 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 2.8 tp -82.82 -15.36 11.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 15' ' ' MET . 23.3 m -80.75 -53.02 6.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.442 -0.787 . . . . 0.0 109.225 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.966 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -63.62 -36.56 84.22 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.08 -1.012 . . . . 0.0 109.346 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.003 HG12 HG12 ' A' ' 44' ' ' ILE . 27.7 m -72.97 -38.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 109.478 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.538 ' HG3' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -48.48 -25.19 1.55 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.663 -1.215 . . . . 0.0 108.371 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -94.47 -24.86 17.12 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.966 HG13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -89.48 -39.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 108.822 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.6 m -83.34 -63.12 1.42 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.34 -23.56 18.11 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 21' ' ' LEU . 15.3 m-20 -108.53 16.95 22.56 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.1 OUTLIER 45.36 34.59 1.56 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' C ' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -10.21 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.002 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 169.12 96.96 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 110.31 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD3' ' CD1' ' A' ' 21' ' ' LEU . 36.1 Cg_endo -79.96 53.09 4.58 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.744 2.296 . . . . 0.0 110.179 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -56.74 118.22 4.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 47.1 83.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 109.634 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.98 13.51 61.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.8 47.34 1.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -1.185 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.905 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -161.77 -66.73 0.06 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -49.5 -32.76 6.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.202 -0.936 . . . . 0.0 108.605 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' CB ' ' HA2' ' A' ' 7' ' ' GLY . . . -81.09 -4.82 56.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.902 -0.499 . . . . 0.0 109.972 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 29' ' ' ASP . 5.8 t -78.49 -21.36 49.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.172 -0.955 . . . . 0.0 109.212 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -106.37 -26.84 11.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.691 ' CB ' HD11 ' A' ' 10' ' ' LEU . 9.8 m -86.73 4.72 39.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.47 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.41 -20.74 8.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.073 -1.017 . . . . 0.0 109.023 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.42 38.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -140.49 -67.74 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -1.102 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -114.36 148.17 38.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.587 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 173.55 142.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.962 . . . . 0.0 109.356 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.53 162.34 21.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.5 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -52.45 -37.8 57.81 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 2.1 m-20 -66.74 -46.19 76.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.206 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -55.05 -23.61 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 0.0 109.101 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.003 HG12 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -66.76 -42.78 89.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD2' HG22 ' A' ' 44' ' ' ILE . 1.2 mpt_? -43.89 -52.83 6.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 7.1 m -73.65 -4.21 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.152 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -102.83 -29.62 11.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -98.75 -43.74 6.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ARG . 10.6 m -148.88 76.31 9.68 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.939 -1.101 . . . . 0.0 110.424 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.3 Cg_endo . . . . . 0 C--N 1.308 -1.569 0 C-N-CA 122.726 2.284 . . . . 0.0 110.275 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.836 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -64.71 145.27 56.45 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.345 -1.091 . . . . 0.0 109.638 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 4' ' ' ARG . 7.3 t -56.82 -160.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.588 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.55 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -43.65 148.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.55 ' N ' ' HG2' ' A' ' 4' ' ' ARG . . . -139.51 92.84 2.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.593 ' O ' HD23 ' A' ' 10' ' ' LEU . 16.3 m -136.49 -77.53 0.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -62.54 -33.91 87.9 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 106.784 -2.526 . . . . 0.0 106.784 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 12' ' ' SER . 12.4 tpp85 -67.46 -46.6 72.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.566 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -52.12 -37.08 53.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.479 -0.763 . . . . 0.0 109.476 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.743 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.0 mm? -68.27 -50.96 50.21 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.359 -0.838 . . . . 0.0 109.32 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.018 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.8 tp -75.0 -16.62 16.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.307 -0.87 . . . . 0.0 108.925 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.7 OUTLIER -74.66 -65.26 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.373 -0.83 . . . . 0.0 109.897 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.814 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.3 pt? -57.36 -34.46 68.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 109.699 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.913 HG12 HG12 ' A' ' 44' ' ' ILE . 26.5 m -77.24 -30.9 17.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.954 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 12' ' ' SER . 2.0 ppp? -50.85 -23.94 3.17 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.339 -1.476 . . . . 0.0 107.901 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.82 -22.8 18.43 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -97.66 -37.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 110.268 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 61.2 m -97.79 -31.25 12.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.5 29.08 70.21 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.39 58.11 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 109.399 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.65 -45.6 0.74 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.595 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -60.63 -71.54 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.602 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 164.79 93.92 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.0 109.796 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.2 Cg_endo -78.46 55.39 5.42 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.569 2.179 . . . . 0.0 110.2 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.43 164.94 6.63 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.383 -0.823 . . . . 0.0 109.714 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 6.9 pt-20 -128.3 69.96 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -87.0 14.42 57.21 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 42.54 50.37 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -1.083 . . . . 0.0 109.54 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.8 ' O ' HG22 ' A' ' 32' ' ' THR . 1.3 m-20 -133.68 -73.43 0.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 109.249 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.808 HD13 ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -53.16 -38.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.159 -0.963 . . . . 0.0 108.918 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HA ' HD21 ' A' ' 10' ' ' LEU . . . -72.78 -2.34 20.08 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.661 -0.65 . . . . 0.0 109.827 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -76.13 -22.58 55.3 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.076 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -106.26 -31.07 8.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.511 -0.743 . . . . 0.0 109.876 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.652 ' CB ' HD11 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -79.68 8.37 6.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.7 -25.91 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 108.379 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.05 45.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -147.64 -54.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.167 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -125.34 131.49 53.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 78.2 m -156.04 -172.71 4.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.259 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 43' ' ' TYR . 0.1 OUTLIER 169.74 141.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -55.57 -41.96 74.06 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.209 -0.932 . . . . 0.0 109.131 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -64.93 -41.7 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.846 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' OH ' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -59.43 -27.11 65.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.913 HG12 HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -62.7 -34.03 63.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -46.78 -54.88 8.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 1.6 m -74.75 -1.28 21.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.808 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -104.16 -27.96 11.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.955 -1.091 . . . . 0.0 108.372 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -97.18 -44.15 7.06 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.75 76.18 6.74 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.917 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 31.4 Cg_endo . . . . . 0 C--N 1.31 -1.472 0 C-N-CA 122.84 2.36 . . . . 0.0 110.389 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.906 0 N-CA-C 119.32 2.488 . . . . 0.0 119.32 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 2.2 pm0 -107.55 143.71 35.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.077 -1.249 . . . . 0.0 109.466 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.2 t -145.04 -162.85 1.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.648 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.579 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 9.2 ttm180 -51.87 148.37 5.9 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.608 0.718 . . . . 0.0 109.344 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . -139.53 90.37 2.4 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 123.074 1.416 . . . . 0.0 108.068 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.3 m -137.57 129.78 29.26 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.854 -1.521 . . . . 0.0 107.417 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 11' ' ' ILE . . . 72.85 -63.06 1.6 Allowed Glycine 0 C--N 1.28 -2.538 0 N-CA-C 105.631 -2.988 . . . . 0.0 105.631 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' CYS . 12.1 tpp180 -65.54 -29.27 69.87 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.773 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 7.8 tttt -62.19 -46.82 87.21 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.426 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.9 mm? -57.92 -41.69 83.24 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.683 -0.635 . . . . 0.0 110.553 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 24' ' ' PRO . 1.1 tp -86.68 -18.9 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.042 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.54 ' O ' ' CG ' ' A' ' 15' ' ' MET . 1.3 m -75.58 -55.43 5.67 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.3 -0.875 . . . . 0.0 108.984 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.829 ' O ' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -63.36 -35.73 81.34 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.001 -1.062 . . . . 0.0 109.869 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.8 m -78.21 -32.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 118.356 -1.338 . . . . 0.0 109.827 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -50.43 -24.67 3.24 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.431 -1.418 . . . . 0.0 107.87 178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -91.76 -23.17 19.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -93.07 -39.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 109.838 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' SG ' HG23 ' A' ' 17' ' ' VAL . 7.6 m -99.92 -35.51 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.352 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 78.61 35.11 33.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.68 55.89 7.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -1.15 . . . . 0.0 109.32 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -134.44 -46.04 0.76 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.384 -0.823 . . . . 0.0 109.772 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -61.32 -74.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.813 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER 166.15 95.06 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.996 . . . . 0.0 109.848 -179.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HB3' HD13 ' A' ' 11' ' ' ILE . 35.5 Cg_endo -78.33 65.93 8.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.584 2.189 . . . . 0.0 110.498 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.415 ' C ' ' HG3' ' A' ' 26' ' ' GLU . 22.9 mt-30 -56.26 167.92 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.247 -0.908 . . . . 0.0 109.818 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 25' ' ' GLN . 1.5 mp0 -138.12 69.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 109.327 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.11 14.26 59.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 44.94 52.95 7.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.499 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.755 ' O ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER -137.98 -67.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.213 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -52.96 -37.78 27.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.181 -0.949 . . . . 0.0 108.808 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -71.67 -4.12 25.53 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.632 -0.668 . . . . 0.0 109.4 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -73.11 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.176 -0.952 . . . . 0.0 109.053 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' OE1' ' CD2' ' A' ' 43' ' ' TYR . 3.2 pt-20 -104.79 -41.19 5.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.839 . . . . 0.0 109.417 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.777 ' HB2' HD11 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -65.86 -17.05 64.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.065 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.66 -24.89 1.52 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.666 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.76 44.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -140.85 -54.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.682 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' CYS . 5.0 mt-30 -146.78 158.3 43.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 109.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 43' ' ' TYR . 0.8 OUTLIER 162.62 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 0.0 109.393 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 p -178.75 163.63 1.47 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.47 -37.11 64.85 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.278 -0.888 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -38.5 71.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.543 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -56.3 -30.44 62.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 108.863 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -59.48 -39.78 80.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 mmm-85 -44.99 -54.78 6.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.532 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 10.2 p -75.89 -2.63 31.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -101.78 -26.72 13.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -101.88 -45.86 5.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.23 74.14 13.01 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 109.929 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.8 Cg_endo . . . . . 0 C--N 1.31 -1.449 0 C-N-CA 122.896 2.398 . . . . 0.0 110.387 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.801 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 131.83 46.87 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.157 -1.202 . . . . 0.0 109.42 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 t -160.61 -163.82 1.13 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 109.685 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -64.11 147.54 52.0 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.565 -0.709 . . . . 0.0 109.442 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 9' ' ' LYS . . . -107.52 75.33 1.01 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 123.113 1.435 . . . . 0.0 108.062 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' ARG . 1.6 m -142.26 125.44 16.4 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.635 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.783 ' HA2' ' HB1' ' A' ' 31' ' ' ALA . . . 72.65 -62.53 1.55 Allowed Glycine 0 C--N 1.285 -2.286 0 N-CA-C 106.106 -2.797 . . . . 0.0 106.106 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -68.46 -27.65 66.36 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.797 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -58.36 -48.08 81.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.589 178.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.8 mm? -55.98 -44.04 78.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.555 -0.716 . . . . 0.0 110.294 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.927 HD13 ' HG3' ' A' ' 24' ' ' PRO . 2.2 tp -80.75 -19.9 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 109.08 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.3 OUTLIER -74.8 -57.21 4.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.852 HD11 HD11 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -62.31 -38.32 88.98 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 109.642 -179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.931 HG12 HG12 ' A' ' 44' ' ' ILE . 33.1 m -74.1 -31.96 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.752 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.551 ' CG ' ' O ' ' A' ' 12' ' ' SER . 1.8 ppp? -50.6 -24.87 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.427 -1.421 . . . . 0.0 107.754 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -89.3 -24.64 21.98 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 14' ' ' VAL . 1.2 m -93.12 -37.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.912 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 17' ' ' VAL . 10.4 m -101.71 -25.48 13.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 15' ' ' MET . . . 56.37 39.81 84.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.56 45.76 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.397 -1.061 . . . . 0.0 108.896 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -118.49 -60.27 1.79 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.447 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -63.3 -38.79 92.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.557 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER 80.74 110.57 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 110.872 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD13 ' A' ' 11' ' ' ILE . 35.6 Cg_endo -78.2 51.44 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.175 1.917 . . . . 0.0 110.296 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 26' ' ' GLU . 6.6 mt-30 -48.95 143.3 5.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.361 -0.837 . . . . 0.0 109.523 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 43.78 55.28 5.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.368 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.75 9.94 61.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 48.68 1.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.862 ' O ' HG22 ' A' ' 32' ' ' THR . 0.4 OUTLIER -157.63 -66.46 0.09 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.979 HD13 ' CB ' ' A' ' 47' ' ' ALA . 1.2 pp -51.91 -40.67 28.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.315 -0.865 . . . . 0.0 108.937 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.783 ' HB1' ' HA2' ' A' ' 7' ' ' GLY . . . -74.05 -3.77 31.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.909 -0.494 . . . . 0.0 110.213 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 29' ' ' ASP . 3.8 t -75.95 -21.75 56.68 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ASN . 7.8 pt-20 -106.1 -26.24 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.65 ' HB2' HD21 ' A' ' 10' ' ' LEU . 5.4 m -82.36 -2.77 53.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.953 . . . . 0.0 110.383 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 7.3 t -67.89 -8.57 37.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.141 -0.974 . . . . 0.0 108.96 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.38 53.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 62.8 t30 -157.04 -65.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.909 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.6 mm-40 -135.82 168.81 18.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 109.986 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER 170.92 159.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.93 160.86 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.022 -1.049 . . . . 0.0 109.852 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.79 -38.28 81.46 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -74.03 -35.91 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.123 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CZ ' ' SG ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -58.53 -26.59 63.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.131 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.931 HG12 HG12 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.53 -29.83 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.389 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -47.97 -50.96 25.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.908 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.519 ' CA ' ' HB3' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -78.33 -2.8 39.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.136 -0.978 . . . . 0.0 110.028 -179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 30' ' ' ILE . . . -101.6 -14.31 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.956 . . . . 0.0 108.661 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -122.93 -38.47 2.61 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -143.95 66.69 15.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.914 -1.116 . . . . 0.0 109.552 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HB3' ' CA ' ' A' ' 46' ' ' SER . 31.9 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.85 2.367 . . . . 0.0 110.371 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.849 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 156.68 17.03 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -1.13 . . . . 0.0 109.867 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -158.05 -164.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.605 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 1.2 tmm_? -64.83 153.82 38.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.6 -0.687 . . . . 0.0 109.279 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 9' ' ' LYS . . . -144.18 95.67 2.76 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' HD23 ' A' ' 10' ' ' LEU . 7.3 m -135.48 -71.45 0.47 Allowed 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 31' ' ' ALA . . . -57.38 -38.94 89.44 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 105.871 -2.892 . . . . 0.0 105.871 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HA ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.14 -45.87 65.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' O ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -51.56 -35.21 40.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.576 -0.702 . . . . 0.0 109.389 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 14' ' ' VAL . 2.6 mm? -72.23 -48.65 41.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.404 -0.81 . . . . 0.0 109.449 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -73.4 -17.94 17.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.168 -0.958 . . . . 0.0 108.573 179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.522 ' O ' ' CG ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -78.09 -59.26 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.496 -0.752 . . . . 0.0 109.613 -179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.905 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -61.52 -34.85 76.22 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.034 -1.041 . . . . 0.0 109.733 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.009 HG12 HG12 ' A' ' 44' ' ' ILE . 35.9 m -74.83 -36.34 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.714 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -49.14 -25.39 2.14 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.48 -1.288 . . . . 0.0 108.116 179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' A' ' 15' ' ' MET . . . -93.48 -24.05 18.15 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -90.05 -37.28 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.181 -0.95 . . . . 0.0 108.91 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 14' ' ' VAL . 34.5 m -89.97 -61.12 1.76 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.47 -22.61 19.45 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 21' ' ' LEU . 14.5 p-10 -114.15 20.34 15.69 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' HG3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 34.08 61.94 0.48 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.747 1.26 . . . . 0.0 110.206 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.501 ' HB3' ' C ' ' A' ' 48' ' ' CYS . 9.2 t -36.6 -56.24 0.83 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.979 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.2 t30 170.67 104.33 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.927 ' HG3' HD21 ' A' ' 21' ' ' LEU . 36.0 Cg_endo -83.05 80.28 2.7 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.72 2.28 . . . . 0.0 110.423 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.36 139.57 19.11 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.352 -0.843 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.71 52.36 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 28' ' ' LYS . . . -103.81 20.8 40.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER 41.88 48.74 3.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.505 -0.997 . . . . 0.0 109.753 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 1.022 ' O ' HG22 ' A' ' 32' ' ' THR . 4.9 m-20 -122.87 -68.18 0.9 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 108.937 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -59.63 -37.09 69.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.154 -0.966 . . . . 0.0 108.789 179.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 10' ' ' LEU . . . -81.59 -3.43 53.33 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.742 -0.599 . . . . 0.0 110.114 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 29' ' ' ASP . 4.2 t -81.69 -18.44 44.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.38 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 34' ' ' CYS . 11.7 pt-20 -105.85 -35.93 7.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.732 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' CB ' HD11 ' A' ' 10' ' ' LEU . 57.7 m -77.87 2.16 18.19 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.352 -0.842 . . . . 0.0 110.249 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.19 -25.68 1.6 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.09 -1.006 . . . . 0.0 108.714 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.9 39.71 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -137.44 -48.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -1.13 . . . . 0.0 109.618 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 32.1 mt-30 -141.18 148.46 40.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 38' ' ' GLN . 0.5 OUTLIER 175.37 138.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 0.0 109.266 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 165.5 34.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.34 -33.8 59.71 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.266 -0.896 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.78 -51.22 51.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.082 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HE1' HD12 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -52.87 -37.79 60.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.009 HG12 HG12 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -52.02 -43.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -44.11 -48.42 9.04 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 109.532 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -74.59 -8.89 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 110.265 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.568 ' HA ' HD13 ' A' ' 30' ' ' ILE . . . -100.18 -25.89 14.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -104.66 -60.43 1.6 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' ARG . 5.7 m -125.31 72.68 66.33 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 110.381 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' A' ' 46' ' ' SER . 30.8 Cg_endo . . . . . 0 C--N 1.308 -1.59 0 C-N-CA 122.882 2.388 . . . . 0.0 110.418 179.073 . . . . . . . . 1 1 . 1 stop_ save_